Biotech and specialty pharma companies at SABCS 2026

Dec 8–11, 2026 San Antonio, TX ~11k attendees Website

35 biotech and specialty pharma companies are at SABCS 2026 — 31 presentations on the program and 11 with a booth in the exhibit hall. Most represented: Greenwich LifeSciences (1 on the program), Celcuity (1 on the program). 11 of them have their own page in this guide. As of Nov 10, 2026.

All 956 organizations at SABCS 2026 →

Focus
Top represented
Showing 1–17 of 35 organizations
OrganizationSABCS 2026 Attendance
Biotech
Clinical-stage biotech testing GP2, a HER2 peptide immunotherapy, in the Phase III Flamingo-01 trial to prevent breast cancer from returning.
Booth
Exhibiting at Booth 809
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Celcuity
Minneapolis, MN
Biotech
Clinical-stage company developing gedatolisib, a PI3K/mTOR pathway inhibitor, for HR+/HER2- advanced breast cancer.
Booth
Exhibiting at Booth 1510
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
BioNTech
Mainz, Germany
Biotech
Biotech company developing mRNA and other cancer immunotherapies and antibody-drug conjugates, including a HER2-directed ADC in breast cancer trials.
Booth
Exhibiting at Booth 251
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Lantern Pharma
Dallas, TX
Biotech
Oncology drug developer using AI and genomics to speed discovery, with candidates for DNA-repair-deficient cancers including triple-negative breast cancer.
Booth
Exhibiting at Booth 1153
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
LeonaBio
Bothell, WA
Biotech
Biotech developing therapies for metastatic breast cancer that no longer responds to treatment, and for ALS.
Booth
Exhibiting at Booth 1431
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Olema Oncology
San Francisco, CA
Biotech
Clinical-stage company developing palazestrant, an oral estrogen receptor antagonist and degrader, in Phase 3 trials for ER+/HER2- advanced breast cancer.
Booth
Exhibiting at Booth 1342
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Puma Biotechnology
Los Angeles, CA
Biotech
Markets NERLYNX (neratinib) for HER2-positive breast cancer and is testing alisertib with hormone therapy in HR+/HER2- metastatic breast cancer.
Booth
Exhibiting at Booth 209
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Relay Therapeutics
Cambridge, MA
Biotech
Clinical-stage company combining computation and experiments to design small-molecule drugs, including a PI3Kα inhibitor for HR+/HER2- breast cancer.
Booth
Exhibiting at Booth 1450
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Biotech
Specialty biopharma company with oncology and rare-disease medicines, including goserelin (Zoladex) in the US.
Booth
Exhibiting at Booth 808
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Corcept Therapeutics
Redwood City, CA
Biotech
Biopharma company developing cortisol-modulating medicines, including relacorilant, for endocrine disorders and cancers such as ovarian cancer.
Booth
Exhibiting at Booth 1632
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Rigel Pharmaceuticals
South San Francisco, CA
Biotech
Commercial-stage biotech marketing medicines for hematology and cancer.
Booth
Exhibiting at Booth 1311
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Biotech
A clinical-stage biopharmaceutical company developing therapies for breast cancer.
Poster
Wed Dec 9
12:30–2pm
Preclinical Evaluation of (Z)-Endoxifen in Estrogen Receptor-Driven Breast Cancer Models
Exhibit Hall
Experimental Therapeutics and Early Phase Trials
BT
BriaCell Therapeutics
Philadelphia, PA
Biotech
A biotechnology company developing immunotherapies for cancer, including breast cancer.
Poster
Fri Dec 11
12:30–2pm
Poster
Fri Dec 11
12:30–2pm
Sapu Bioscience
San Diego, CA
Biotech
An immuno-oncology company developing RNA therapeutics and small-molecule drugs for cancer and infectious diseases.
Poster
Wed Dec 9
12:30–2pm
Poster
Thu Dec 10
12:30–2pm
Artificial Intelligence-Guided Biological Knowledge Integration Identifies FOXM1 and E2F1 as Master Regulators for mTOR Signaling
Exhibit Hall
Artificial Intelligence, Computational Biology, and Systems Biology
AT
Atheron Therapeutics
Shanghai, China
Biotech
A biotechnology company with research and development operations in Shanghai.
Ajinomoto do Brasil
São Paulo, Brazil
Biotech
Brazilian subsidiary of Ajinomoto, developing food, nutrition and amino-acid solutions through its AminoScience research and business activities.
Poster
Wed Dec 9
12:30–2pm
Effect of Monosodium Glutamate on Hyposalivation in Patients with Breast Cancer Undergoing Chemotherapy
Exhibit Hall
Adverse Effects of Cancer Treatment and Symptom Management
Biotech
Clinical-stage biotechnology company developing an investigational cancer immunotherapy for adult and pediatric cancers.
Poster
Wed Dec 9
5–6:30pm

Explore the full SABCS 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full SABCS 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from biotech and specialty pharma companies

Tell us what you sell and we’ll find the people at these biotech and specialty pharma companies most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse SABCS 2026 by

Exhibit hall

Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction